Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Augmentin 250/62 oral suspension (GlaxoSmithKline UK Ltd) |
| BNF code | 0501013K0BBANAI |
| Virtual Medicinal Product | Co-amoxiclav 250mg/62mg/5ml oral suspension |
| Name | Augmentin 250/62 oral suspension |
| Supplier | GlaxoSmithKline UK Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Oral |
| Actual Medicinal Product Packs | |
| Augmentin 250/62 oral suspension (GlaxoSmithKline UK Ltd) 100 ml | |
dm+d data retrieved from TRUD: release NHSBSA_2.2.0_20250217000001, imported on 18th February 2025 at 03:53:40.